Regenerex Pharma (RGPX) Common Equity (2010 - 2025)
Regenerex Pharma (RGPX) reported Common Equity of -$4.7 million for Q3 2025, up 1.23% year-over-year from -$4.6 million in Q3 2024, and down 3.32% on a QoQ basis from -$4.5 million in Q2 2025.
Regenerex Pharma (RGPX) has 14 years of Common Equity data on file, last reported at -$4.7 million in Q3 2025.
- Quarterly Common Equity rose 1.23% year-over-year to -$4.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$4.7 million (up 1.23% YoY) and the FY2025 annual result came in at -$4.2 million, down 2.32% from the prior year.
- Common Equity retreated to -$4.7 million in Q3 2025 per RGPX's latest filing, from -$4.5 million in the prior quarter.
- Across five years, Common Equity topped out at -$835026.0 in Q1 2021 and bottomed at -$5.1 million in Q4 2024.
- The 5-year median for Common Equity is -$1.1 million (2023), against an average of -$2.6 million.
- The widest annual swing landed in 2024, when Common Equity plunged 297.93%; it then advanced 1.23% in 2025.
- Tracing RGPX's Common Equity over 5 years: stood at -$937168.0 in 2021, then dropped by 14.88% to -$1.1 million in 2022, then tumbled by 260.01% to -$3.9 million in 2023, then sank by 30.38% to -$5.1 million in 2024, then rose by 7.02% to -$4.7 million in 2025.
- Per Business Quant, the three latest RGPX Common Equity figures stand at -$4.7 million (Q3 2025), -$4.5 million (Q2 2025), and -$4.2 million (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4.70 Mn |
| Jun 30, 2025 | -4.55 Mn |
| Mar 31, 2025 | -4.16 Mn |
| Dec 31, 2024 | -5.05 Mn |
| Sep 30, 2024 | -4.76 Mn |
| Jun 30, 2024 | -4.31 Mn |
| Mar 31, 2024 | -4.06 Mn |
| Dec 31, 2023 | -3.88 Mn |
| Sep 30, 2023 | -3.63 Mn |
| Jun 30, 2023 | -1.08 Mn |
| Mar 31, 2023 | -1.12 Mn |
| Dec 31, 2022 | -1.08 Mn |
| Sep 30, 2022 | -1.03 Mn |
| Jun 30, 2022 | -1.01 Mn |
| Mar 31, 2022 | -985,617.00 |
| Dec 31, 2021 | -937,168.00 |
| Sep 30, 2021 | -902,734.00 |
| Jun 30, 2021 | -868,978.00 |
| Mar 21, 2021 | -835,026.00 |
| Dec 31, 2020 | -550,546.00 |
| Sep 30, 2020 | -516,863.00 |
| Jun 30, 2020 | -491,091.00 |
| Mar 31, 2020 | -481,274.00 |
| Dec 31, 2019 | -440,978.00 |
| Sep 30, 2019 | -420,424.00 |
| Jun 30, 2019 | -401,954.00 |
| Mar 31, 2019 | -369,685.00 |
| Dec 31, 2018 | -353,233.00 |
| Sep 30, 2018 | -344,488.00 |
| Jun 30, 2018 | -339,679.00 |
| Mar 31, 2018 | -321,106.00 |
| Dec 31, 2017 | -317,356.00 |
| Sep 30, 2017 | -306,915.00 |
| Jun 30, 2017 | -298,788.00 |
| Mar 31, 2017 | -321,106.00 |
| Nov 30, 2014 | -693,479.00 |
| Aug 31, 2014 | -742,706.00 |
| May 31, 2014 | -693,479.00 |
| Feb 28, 2014 | -1.86 Mn |
| Nov 30, 2013 | -1.70 Mn |
| Aug 31, 2013 | -1.44 Mn |
| May 31, 2013 | -1.22 Mn |
| Feb 28, 2013 | -994,020.00 |
| Nov 30, 2012 | -749,656.00 |
| Aug 31, 2012 | -285,057.00 |
| May 31, 2012 | -280,636.00 |
| Feb 29, 2012 | -277,478.00 |
| Nov 30, 2011 | -122,340.00 |
| Aug 31, 2011 | 339,076.00 |
| Nov 30, 2010 | -22,843.00 |
| Aug 31, 2010 | -13,817.00 |